Optimal Radiation Dose for Stage III Lung Cancer—Should “Definitive” Radiation Doses Be Used in the Preoperative Setting?

Optimal Radiation Dose for Stage III Lung Cancer—Should “Definitive” Radiation Doses Be Used in the Preoperative Setting?

Introduction: There are currently two recommended radiation strategies for clinical stage III NSCLC: a lower “preoperative” (45–54 Gy) and a higher “definitive/nonsurgical” (60–70 Gy) dose. We sought to determine if definitive radiation doses should be used in the preoperative setting given that man...

Full description

Bibliographic Details
Main Authors: Areo G. Saffarzadeh, MD, MS, Maureen Canavan, PhD, MPH, Benjamin J. Resio, MD, Samantha L. Walters, MHS, Kaitlin M. Flores, Roy H. Decker, MD, PhD, Daniel J. Boffa, MD
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:JTO Clinical and Research Reports
Subjects:
Non–small cell lung cancer (NSCLC)
Radiation dose
Stage III
National Cancer Database (NCDB)
Chemoradiotherapy
Neoadjuvant
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364321000606

Similar Items

Similar Items